http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5462053-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76ba102ea9c02b6633d64bf09c5b89a4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-5601
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1806
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-28
filingDate 1994-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1995-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1163e2914d69998e5cd2c2f5c26f2d0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24ef82eb12a7a6b7da655975439b6d41
publicationDate 1995-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5462053-A
titleOfInvention Stable artifact-free imaging contrast suspension agent
abstract A contrast agent adapted for magnetic resonance imaging of a sample, the contrast agent comprising a suspension in a medium acceptable for magnetic resonance imaging of (a) coated particles of a contrast agent possessing paramagnetic characteristics and (b) coated particles of a contrast agent possessing diamagnetic characteristics, each of the coatings being selected from a group of materials which [I] renders the coated particles (a) and (b) substantially comparable with and substantially biologically and substantially chemically inert to each other and the environments to which the contrast agent is exposed during magnetic resonance imaging and [II] which substantially stabilizes the suspension; the nature of each of the coatings and the relative amounts of (a) and (b) in the suspension being such that the positive magnetic susceptibility of (a) substantially offsets the negative magnetic susceptibility of (b) and the resulting suspension has substantially zero magnetic susceptibility and, when employed in magnetic resonance imaging, results in the substantial elimination of imaging artifacts. Also disclosed is a method of imaging a sample which comprises introducing into the sample the above-described contrast agent and generating an image thereof.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100967795-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006235292-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6553249-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010259259-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005019264-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003167006-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6525862-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7966056-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012121430-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8974363-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6986740-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8557298-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9961070-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8961935-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6519076-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7473843-B2
priorityDate 1992-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4827945-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5023072-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5362478-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4749560-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5128121-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4863715-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5055288-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4770183-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4951675-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4731239-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5262176-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5069216-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135893138
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7107
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21867792
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136080371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421769
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466

Total number of triples: 55.